Sugi Predict

Sugi Predict / Compounds / SCHEMBL20924693

SCHEMBL20924693

SCHEMBL20924693

O=C(O)c1ccc(F)c(F)c1CSc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FFAR1 O14842 1/20 0.44
▸ KMT2A Q03164 4/20 0.41
▸ LMNA P02545 4/20 0.40
▸ MEN1 O00255 3/20 0.40
▸ CYP1A2 P05177 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ CES2 O00748 1/20 0.38
▸ CES1 P23141 1/20 0.38
▸ ALDH1A1 P00352 4/20 0.37
▸ KDM4E B2RXH2 1/20 0.36
▸ MAPT P10636 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.35
▸ ALOX15 P16050 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ ALB P02768 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ACMSD Q8TDX5 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21627106 0.84 L3MBTL1 (0.47) FFAR1KMT2ALMNAMEN1CYP1A2
SCHEMBL28272240 0.83 ALB (0.47) FFAR1KMT2ALMNAMEN1CYP1A2
SCHEMBL22261444 0.81 CYP1A2 (0.41) LMNACYP1A2TDP1L3MBTL1CES2
SCHEMBL30219210 0.81 CYP1A2 (0.41) LMNACYP1A2TDP1L3MBTL1CES2
SCHEMBL22639060 0.81 CES2 (0.33) CES2CES1ACMSD
SCHEMBL29027178 0.80 ALDH1A1 (0.44) KMT2ALMNAMEN1CES2CES1
SCHEMBL22261513 0.79 NR4A1 (0.43) FFAR1KMT2ALMNAMEN1CYP1A2
SCHEMBL22639071 0.79 NPC1 (0.39) KMT2ALMNAMEN1CES2CES1
SCHEMBL22335182 0.76 ALDH1A1 (0.38) FFAR1KMT2ALMNAMEN1CYP1A2
SCHEMBL28466939 0.76 ALDH1A1 (0.38) FFAR1KMT2ALMNAMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109721585-B Preparation method of baroxavir key intermediate 浙江工业大学 2020-09-29 — — CN claimed
CN-110790690-A Synthetic method of 3, 4-difluoro-2- ((phenylthio) methyl) benzoic acid 湖南师范大学 2020-02-14 — — CN claimed
CN-110143941-A A kind of synthetic method of Barrow Sa Weimabo ester intermediate 北京四环制药有限公司 2019-08-20 — — CN claimed
CN-115974834-B Method for preparing thia compound by continuous reaction 北京理工大学 2024-10-18 — — CN disclosed
US-20240025921-A1 PYRIDONE MULTIPLE-MEMBERED RING DERIVATIVES AND USE THEREOF PHAENO THERAPEUTICS CO., LTD. (CN) 2024-01-25 — — US disclosed
CN-114907365-B Influenza virus inhibitor and application thereof 扬子江药业集团有限公司 2023-12-01 — — CN disclosed
CN-117120441-A Influenza virus inhibitor and application thereof 扬子江药业集团有限公司 2023-11-24 — — CN disclosed
EP-4276099-A1 PYRIDONE MULTIPLE-MEMBERED RING DERIVATIVES AND USE THEREOF Phaeno Therapeutics Co., Ltd. (CN) 2023-11-15 — — EP disclosed
US-11807648-B2 Process for preparing substituted polycyclic pyridone derivative and crystal thereof SHIONOGI & CO., LTD. (JP) 2023-11-07 — — US disclosed
US-11752214-B2 Protein-antiviral compound conjugates REGENERON PHARMACEUTICALS, INC. (US) 2023-09-12 — — US disclosed
US-11752214-B2 Protein-antiviral compound conjugates REGENERON PHARMACEUTICALS, INC. (US) 2023-09-12 — — US disclosed
CN-109721585-B Preparation method of baroxavir key intermediate 浙江工业大学 2020-09-29 — — CN disclosed
CN-109721585-B Preparation method of baroxavir key intermediate 浙江工业大学 2020-09-29 — — CN disclosed
CN-110790690-A Synthetic method of 3, 4-difluoro-2- ((phenylthio) methyl) benzoic acid 湖南师范大学 2020-02-14 — — CN disclosed
CN-110790690-A Synthetic method of 3, 4-difluoro-2- ((phenylthio) methyl) benzoic acid 湖南师范大学 2020-02-14 — — CN disclosed
CN-110790690-A Synthetic method of 3, 4-difluoro-2- ((phenylthio) methyl) benzoic acid 湖南师范大学 2020-02-14 — — CN disclosed
WO-2020020267-A1 SUBSTITUTED POLYCYCLIC PYRIDONE COMPOUND AND PRODRUG THEREOF 深圳市塔吉瑞生物医药有限公司 2020-01-30 — — WO disclosed
WO-2020015669-A1 ANTI-INFLUENZA VIRUS TRICYCLIC DERIVATIVE 南京明德新药研发有限公司 2020-01-23 — — WO disclosed
CN-110698451-A Substituted dibenzo [ b, e ] thio (oxy) heptacyclo-11 (6H) -ketone compound and preparation method thereof 山东诚汇双达药业有限公司 2020-01-17 — — CN disclosed
EP-3473629-A1 METHOD FOR PRODUCING SUBSTITUTED POLYCYCLIC PYRIDONE DERIVATIVE AND CRYSTAL OF SAME Shionogi & Co., Ltd. (JP) 2019-04-24 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11807648-B2 Process for preparing substituted polycyclic pyridone derivative and crystal thereof REN, C5, PDXK FFAR1 3112/4885KMT2A 1192/4885LMNA 1586/4885
US-20240025921-A1 PYRIDONE MULTIPLE-MEMBERED RING DERIVATIVES AND USE THEREOF CYP2B6, SLC5A6, CYP2D6 FFAR1 3459/4885KMT2A 2693/4885LMNA 3902/4885
US-11752214-B2 Protein-antiviral compound conjugates BMX, SARS1, VSIG8 FFAR1 3017/4885KMT2A 3130/4885LMNA 3007/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.